Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
---|---|---|---|---|---|---|---|---|
BMY | BRISTOL MYERS SQUIBB CO | United States | $97.67B | 2,022,193,411 | 76.46% | 0.36% | Net Selling | Net Selling |
JNJ | JOHNSON & JOHNSON | United States | $351.05B | 2,408,767,228 | 69.52% | 0.19% | Net Selling | Net Selling |
GILD | GILEAD SCIENCES INC | United States | $82.42B | 1,245,774,616 | 83.54% | 1.09% | Net Selling | Net Selling |
AZN | ASTRAZENECA PLC | United Kingdom | $211.94B | 1,550,162,626 | 31.49% | 0.00% | ||
SNY | SANOFI | France | $114.82B | 1,264,799,969 | 19.51% | 0.00% | ||
GSK | GSK PLC | United Kingdom | $79.64B | 4,056,000,000 | 7.26% | 0.00% | ||
NVS | NOVARTIS AG | Switzerland | $189.22B | 2,044,033,986 | 6.92% | 0.00% | ||
PFE | PFIZER INC | United States | $143.37B | 5,646,778,425 | 68.45% | 0.27% | Net Selling | Net Selling |
BIIB | BIOGEN INC | United States | $27.69B | 145,360,798 | 87.86% | 2.11% | Net Selling | Net Selling |
LLY | ELI LILLY & CO | United States | $708.78B | 950,164,452 | 82.44% | 11.18% | Net Selling | Net Selling |
AMGN | AMGEN INC | United States | $140.81B | 535,918,901 | 76.49% | 1.01% | Net Selling | Net Selling |
MRK | MERCK & CO INC | United States | $317.16B | 2,532,643,872 | 76.17% | 0.19% | Net Buying | Net Buying |
ABBV | ABBVIE INC | United States | $290.87B | 1,766,473,359 | 70.16% | 0.15% | Net Selling | Net Selling |
GRFS | GRIFOLS SA | United States | $4.50B | 687,554,908 | 17.73% | 0.00% | ||
AMRN | AMARIN CORP PLC | Ireland | $358.11M | 410,671,800 | 22.86% | 15.41% | Net Selling | Net Selling |
OGN | ORGANON & CO | United States | $4.57B | 255,638,256 | 77.39% | 0.19% | Net Selling | Net Selling |
SCLX | SCILEX HOLDING CO | United States | $149.57M | 166,189,835 | 15.74% | 37.69% |